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Abstract
Simian immunodeficiency virus (SIV) infection leads to AIDS in experimentally infected macaques, whereas natural reservoir
hosts exhibit limited disease and pathology. It is, however, unclear how natural hosts can sustain high viral loads,
comparable to those observed in the pathogenic model, without developing severe disease. We performed transcriptional
profiling on lymph node, blood, and colon samples from African green monkeys (natural host model) and Asian pigtailed
macaques (pathogenic model) to directly compare gene expression patterns during acute pathogenic versus non-
pathogenic SIV infection. The majority of gene expression changes that were unique to either model were detected in the
lymph nodes at the time of peak viral load. Results suggest a shift toward cellular stress pathways and Th1 profiles during
pathogenic infection, with strong and sustained type I and II interferon responses. In contrast, a strong type I interferon
response was initially induced during non-pathogenic infection but resolved after peak viral load. The natural host also
exhibited controlled Th1 profiles and better preservation of overall cell homeostasis. This study identified gene expression
patterns that are specific to disease susceptibility, tissue compartmentalization, and infection duration. These patterns
provide a unique view of how host responses differ depending upon lentiviral infection outcome.
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Introduction
Natural reservoir hosts of simian immunodeficiency virus (SIV)
do not develop AIDS in response to infection and live a normal
lifespan. This is in contrast to non-natural hosts, such as Asian pig-
tailed macaques (PTs), which, when experimentally infected with
SIV, develop AIDS in a similar manner to HIV-infected humans
[1,2]. Pathogenic SIV infection is characterized by high viral
replication, loss of CD4+ T cells, high immune activation, T cell
apoptosis, and ultimately, AIDS [3–5]. SIV-infected natural hosts,
such as African green monkeys (AGMs), retain stable CD4+ T cell
counts in peripheral blood even in the presence of viral loads (VLs)
as high as those observed during pathogenic infection [6–8]. Given
this dichotomy, insight into the mechanisms of HIV pathogenesis
might be gained by comparing the transcriptional response of
natural and non-natural hosts to SIV infection.
High levels of viral replication and the loss of CD4+ T cells
correlate with faster disease progression in pathogenic SIV/HIV
infection [9–11]. Diseased hosts also exhibit substantial loss of
uninfected CD4+ and CD8+ T cells as a result of activation-
induced cell death [12,13]. It is thought that adaptive (T and B
cell) antiviral immune responses may serve to control viral
replication and spread [14,15]. Yet, high levels of CD8+ T cell
activation are also predictive of disease progression [16–18].
Cytotoxic T cell (CTL) responses are associated with increased
induction of inflammatory cytokines, which in turn also correlate
with pathogenesis. Conversely, control of immune activation in
non-pathogenic infection may relate to anti-inflammatory
cytokine profiles (reviewed in [19]). Dysregulation of the pro-
inflammatory response has been reported in pathogenic lentiviral
infections, often as a result of cytokine induction by viral proteins
[20,21]. Secretion of CC-chemokines has been associated with
an HIV-induced proinflammatory cytokine profile [22,23], and
molecules such as interferon gamma (IFNc) are up-regulated in
lymphoid tissues of SIV-infected rhesus macaques [24,25].
Although IFN responses are critical components of the innate
immune response to viral pathogens, type 1 interferon expression
is elevated in the acute phase of pathogenic SIV infection of non-
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human primates (NHPs) and persists in lymphoid tissue but fails
to control viral replication [25,26]. Additionally, a strong innate
response to SIV often includes induction of genes recognizing
pathogen-associated molecular patterns (PAMPs). It has been
proposed that increased expression of inflammatory mediators
may be a result of general immune activation caused by Toll-like
receptor (TLR) induction by bacterial products escaping the gut
[27]. Such bacterial translocation may be a result of epithelial
damage from a sustained pro-inflammatory environment in the
gut mucosa [28].
Increased levels of pro-inflammatory cytokines in HIV and
pathogenic SIV infections have also been associated with T cell
apoptosis via tumor necrosis factor (TNF)/FAS death receptor
signaling pathways [29–31]. Lower levels of immune activation
have been correlated with decreased FAS-induced cell death in
HIV patients undergoing retroviral therapy [32], and levels of
immune activation and T cell apoptosis are low in natural SIV
hosts with non-pathogenic infections [8,33,34]. Conversely,
bystander activation induced cell death is associated with higher
levels of T cell activation [12,13,35]. Excessive early T cell
apoptosis has been examined in pathogenic SIV models [36,37]
and has been proposed as a mechanism for pathogenesis. A
positive correlation between primary acute-phase apoptotic levels
in peripheral lymphoid tissue and disease progression in rhesus
macaques has been demonstrated [36]. In addition to sustained
immune activation, T cell apoptosis in pathogenic models may be
linked to dysregulation of the cell cycle, as perturbations have been
observed in lymph nodes of SIV-infected macaques but not in
naturally-infected sooty mangabeys [38].
The mechanisms by which inflammatory responses, T cell
activation, and apoptosis are induced, sustained, or suppressed
differentially between pathogenic and non-pathogenic infections
remain unclear. To delineate such mechanisms, we performed a
longitudinal genomic analysis comparing the transcriptional
responses of natural (AGM) and non-natural (PT) hosts in the
setting of acute SIV infection with the same primary isolate
(SIVagm.sab92018). For the microarray experiments, each animal
was its own genetically matched control for assessing gene
expression changes, with multiple animals for each experimental
condition, enabling us to perform statistical tests to identify those
gene expression changes that distinguish pathogenic from non-
pathogenic SIV infection. Our observations revealed that SIV
induced host-specific global gene expression patterns in lymph
node (LN), blood, and colon. In more than one respect, this study
provides a unique view of lentiviral infection in vivo. First, we now
have a global perspective of the host transcriptional response to
SIV in pathogenic and non-pathogenic models. Second, several
tissues that are known to be affected by lentiviruses were examined
at multiple time points, thus providing significant insight into the
dynamics of the acute phase of infection. Our analysis of these
tissues separately and over time has revealed new insights into the
kinetics and compartmentalization of interactions between virus
and host.
Results
We examined the global gene expression changes that occur
during the acute phase of pathogenic and non-pathogenic SIV
infection in NHPs. Four PT macaques (Macaca nemestrina) and four
AGMs (Chlorocebus sabaeus) were each infected intravenously with
600 TCID50 of SIVagm.Sab92018 [6]. The course of infection
was followed for 6 weeks, and LN, blood, and colon biopsies were
collected from each animal at baseline (day 214), at peak viremia
(day 10), and at the conclusion of the experiment (days 45 or 49,
referred to as ‘‘day 45+’’). For each microarray experiment,
mRNA levels from individual animals were compared to those at
baseline (day 214) for the same animal. Extensive virologic,
immunologic, and histologic characterizations were also per-
formed with these and additional samples, and are described in
part in a separate manuscript [39]. SIV viremia was detectable in
PTs and AGMs by day 3 post-infection and reached high peak
levels (exceeding 108 RNA copies/ml) in the blood by day 10, after
which it declined and remained stable at high viral ‘‘set-points’’
(Figure S1A). In the PT relative to the AGM, there were increased
viral loads that reached statistical significance (P,0.02) in
peripheral blood mononuclear cells (PBMCs) (at day 3), colon
(at day 10), and lymph node (at day 45+). Otherwise, cellular RNA
viral load ranges were similar between the two species. After
infection, CD4+ T cell counts and frequencies remained stable in
the blood and lymph nodes of AGMs but were rapidly depleted in
PTs (Figure S1B). By contrast, and as recently reported [40,41],
CD4+ T cell depletion in the colon was similar in magnitude and
kinetics in both species, with the frequency declining to low levels
by day 10.
The overall effect on host gene expression during the first weeks
of SIV infection was significant. As shown in Figure 1, the
expression levels of 9,470 genes on the array changed at least 2
fold in a minimum of 2 experiments, relative to pre-infection levels
(P#0.05). With unsupervised clustering, expression patterns of
each tissue were distinct, with the highest levels of post-infection
induction in LN, where there was a clear separation of PTs from
AGMs. Genes differentially expressed in blood clustered closest to
the LNs and both tissues shared many patterns, to varying degrees.
Expression patterns in colon were distinct from all other samples,
and samples separated based on time post-infection, rather than by
species.
Overall gene expression changes in pathogenic and non-
pathogenic SIV infection
A quantitative depiction of differential gene expression is
shown in Figure 2A and 2B. For this and all ensuing analysis,
data points for four animals per species/tissue/timepoint were
used (excluding AGM-3 and PT-3 at day 45+ in LNs, and PT-2
in colon at day 10, due to sampling errors). Overall, the greatest
differential regulation of genes occurred in the LNs of infected
animals, and the total number of differentially expressed genes
was comparable between AGMs and PTs. The number of
differentially regulated genes in the peripheral blood was
Author Summary
Simian immunodeficiency virus (SIV) does not cause
disease in African green monkeys (a natural host for the
virus), whereas experimentally infected Asian macaques (a
non-natural host) develop a progressive disease that is
similar to that which occurs in HIV-infected humans.
Insight into how HIV causes disease and leads to
development of AIDS may therefore be gained by
comparing the response of natural and non-natural hosts
to SIV infection. To this end, we examined changes that
occurred in gene expression levels over time and in
multiple tissues derived from African green monkeys and
Asian macaques experimentally infected with SIV. Infection
leads to host-specific gene expression patterns in lymph
nodes, blood, and colon. The natural and non-natural
hosts differed with respect to the timing, intensity, and
duration of infection-induced gene expression changes
associated with inflammation and response to stress.
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relatively consistent between day 10 and 45+, though more
changes overall were observed in PTs as compared to AGMs. In
the colon of both species, the number of differentially expressed
genes was greater at day 45+ (a time when viral set point had
been established) than at day 10 (peak VL).
To identify genes whose expression was statistically different
between the two species (and which therefore might be related to
disease outcome), we performed error-weighted statistical tests
(one-way ANOVA) on data collected from all animals at each time
point, directly comparing AGM to PT for each tissue. Figure 2C is
a summary of the total number of genes that were significantly
different by species. Despite having comparable numbers of
differentially regulated genes at day 10 in LNs, there were over
600 genes expressed at significantly different levels in the AGMs
vs. PTs at this time. In all tissues, it was evident that the most gene
expression changes distinguishing species were found at viral peak
(day 10), with fewer distinguishing expression profiles at day 45+.
In addition to comparing the species at each time-point by species
ANOVA, we examined kinetics by comparisons of total gene
expression changes between peak VL (day 10) and viral set-points
(day 45+) in each species by time ANOVA (Figure 2D).
Significantly more time-dependent changes occurred in the colon
of both species than in blood or LN. These results suggest that
events which occur during the very acute phase of infection play a
key role in disease outcome.
Evidence for stress responses and apoptosis during early
SIV infection in the lymph nodes
As most SIV-specific gene expression regulation was found in
lymph nodes, we focused much of our subsequent analysis on this
tissue. Based on one-way species ANOVA comparing PTs to
AGMs, we identified 618 genes whose expression levels at day 10
were significantly different between the two species (Figure 2C).
Gene ontology analysis revealed that the majority of these genes
were associated with either immune responses or cell death
(Figure 3A), with redundancies in the categories of hematological
system development, cell movement, and inflammatory disease.
Because the top categories are very broad, genes were further
subdivided based on available annotations for additional insight
into possible differences in cell processes.
Figure 1. Global gene expression analysis in blood, lymph node, and colon during acute SIV infection of African green monkeys
and Pigtails. Two-dimensional hierarchical clustering was done using Resolver System software with an agglomerative algorithm, average link
heuristic criteria, and Cosine correlation metric. Each column represents gene expression data from an individual experiment, including all PTs
(orange highlight) and AGMs (green highlight) at days 10 or 45+ post-infection, and all tissues. The cluster represents genes that showed $2-fold
change (P#0.05) in at least two experiments. Genes in red are up-regulated, and genes in green are down-regulated, as compared to pre-infection
levels for each animal.
doi:10.1371/journal.ppat.1000296.g001
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Genes associated with cell death (shown in Figure 3B and Table
S1) included those mediating death receptor signaling, apoptosis,
cell cycle arrest and progression, caspase activation, DNA damage
response, or oxidative stress. Although there were numerous genes
associated with death receptor signaling, there did not appear to
be a species bias towards pro- or anti- FAS-mediated apoptosis.
Genes more highly induced in AGMs included UNC5B and
STK11 (known to play a role in FAS-mediated apoptosis and
associated with p53 signaling) and TRADD and IER3, which are
positive or negative regulators of the FAS pathway, respectively.
Genes that were more highly induced in PTs have functions more
pertinent to the negative regulation of death receptor signaling
(e.g., ASAH1, BTK, and CFLAR) and of apoptosis (e.g., IDE,
CAMK2D, and LGALS3). Genes associated with oxidative stress
and DNA damage (e.g., SOD2, DLST, GLRX, RRM2, YWHAE,
and RAD51L3) also showed higher levels of induction in PTs.
Collectively, these patterns are consistent with the possibility that
oxidative stress is more prominent in pathogenic infection,
prompting the induction of cellular genes that serve a protective
role against oxidative stress, DNA damage, and apoptosis. Cell
death genes related to the cell cycle were also differentially
regulated between species. In general, a greater proportion of
these genes were induced in AGMs (e.g., AXL, CDN2D, and
MYCN), including those known to be responsible for both
progression and arrest of the cell cycle.
Gene expression associated with Th1 response,
inflammation, and cytotoxic T lymphocyte (CTL)
signaling in lymph nodes of non-natural hosts
Immune response genes that significantly distinguished the two
species at peak VL (day 10) in lymph nodes consisted mainly of
those associated with T and B cell signaling and with chemotaxis
of immune cells (Figure 3C, Table S2). Compared to AGMs,
significantly more genes were highly induced in PTs and they
exhibited a trend towards Th1 differentiation and proliferation,
cytotoxic T cell activity, and IFNc signalling. These genes
included inflammatory mediators (e.g., CXCL9 and 10, CCL3,
CTSC, and CCR2) as well as genes necessary for antigen
presentation or CTL responses (e.g., CD86, CD84, CD8a,
GZMA, GZMB, CLEC4A and KLRC1). Although not identified
by the ANOVA, PTs displayed a trend towards higher expression
of additional genes for antigen-presentation (e.g., CCL17, CD80,
Figure 2. Quantitative analysis of total gene expression changes in blood (BL), colon (CO), and lymph node (LN) biopsies during
acute SIV infection. Total number of differentially-expressed genes ($2-fold change, P#0.05) in AGMs (A) and PTs (B) for each tissue and time-
point. Numbers are generated from in-silico pools of four animals/species/time point. (C) Numbers of genes identified by ANOVA (P#0.01)
distinguishing AGMs from PTs at day 10 or day 45+ in each tissue and species (D). Numbers of genes identified by ANOVA (P#0.01) distinguishing day
10 from day 45+. Genes depicted in C and D were 2-fold regulated (P#0.05) in at least 2 of 8 animals.
doi:10.1371/journal.ppat.1000296.g002
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GBP3, and ICOS), dendritic cell recruitment/maturation (e.g.,
ADAMDEC1, CCR7, ISGF6, and LAMP3), and CTL responses
(e.g., CD2, CCL20, CLEC7A, and SRGN). These patterns are
consistent with other studies showing that pathogenic infections
can be associated with robust Th1 responses [34,42,43].
In PTs, significantly higher expression of T cell chemokine
genes from the day 10 species ANOVA was consistent with a
generally higher level of immune activation in this species, as
evidenced by the presence of significantly more CD8+ T cell
activation in PT LNs (by Ki67 levels) at both day 10 and day 45+
[39]. High induction of pattern-recognition receptors (e.g.,
CLEC7A, TLR2, and TL8) in PTs also suggest a strong innate
immune response. Many genes regulating neutrophil chemotaxis
and degranulation (e.g., LY75, LYZ, FCGR3B, CSF2BA,
CEBPA, and B4GALT1) were only induced in PTs. A greater
number of genes associated with calcium signaling was also
Figure 3. Gene ontology analysis of genes that statistically distinguish AGMs from PTs in lymph nodes at viral peak. (A) Gene
annotation was performed using Ingenuity Pathway Analysis. Bars represent percent of genes in each category based on total numbers of annotated
ANOVA set genes. (B) Expression profiles of 124 cell death-related genes from LN day 10 species ANOVA. (C) Expression profiles of 84 immune-
response related genes from LN day 10 species ANOVA. Each column represents gene expression data from an individual animal with green and red
colors showing decreased or increased levels of mRNA expression relative to d-14, respectively. Gene names for B and C are listed in Tables S1 and S2,
respectively.
doi:10.1371/journal.ppat.1000296.g003
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induced in PTs, possibly reflecting the use of calcium-signaling
pathways by broadly induced chemokines. Interestingly, the HIV/
SIV co-receptor CCR5 was induced in all animals but at
significantly higher levels in PTs than AGMs, in support of
previous observations [44] and with a proposed model of restricted
CCR5 expression in natural SIV hosts [19].
From the above LN d10 ANOVA, a subset of 137 genes showed
increased expression only in PTs but decreased expression or no
change in AGMs (Table S3). These genes encode mediators of
inflammation, apoptosis, proliferation, and IFNc signaling. Gene
ontology analysis of this subset identified a significant network
linked to IFNc signaling and included genes that positively
regulate or are regulated by IFN-c (e.g., IL12RB2, RARRES1,
GPNMB and NUP98) (Figure 4A). Others (e.g., CALU,
HNRNPC, LMAN1, and PDCD6) are linked to calcium signaling,
consistent with the data shown in Figure 3C. As genes in this
network were down-regulated in AGMs (Figure 4B), these
observations underscore the premise that T cell proliferation and
strong Th1 responses are more specific to pathogenic than
nonpathogenic SIV infection and, reciprocally, suggest an
important role for the regulation of proliferation and inflammation
in early stages of non-pathogenic SIV infection.
Specific induction of genes associated with
hematolymphoid system regeneration and resolution of
Th1 signaling in AGMs
In contrast to PTs, highly-expressed genes in AGMs (day 10
species ANOVA, Figure 3) were associated with the control of an
inflammatory/Th1 response and the development of hemato-
poietic progenitors. Notably, the AGMs showed up-regulation of
the cytokine IL10, a potent anti-inflammatory mediator and
negative regulator of Th1 cytokine production, as well as
NLRP3, which is associated with prevention of inappropriate
inflammatory responses [45]. This suggests a more active control
of the inflammatory response in AGMs. CCL25, a B-cell
chemokine and promoter of IgA production, was also induced
at higher levels in AGMs. Genes associated with mast cell
accumulation and degranulation included COL17A1, CCL2,
and LTC4S [46]. Many additional genes induced in AGMs, or
down-regulated in PTs, were associated with eosinophil migra-
tion or myeloid chemotaxis and growth (e.g., CCL2, IL10,
LTC4S, CCL11, MADCAM1, and PLA2G6), or the develop-
ment of hematopoietic progenitors (e.g., THY1/CD90, CD33,
and CD34). Genes associated with the proliferation or differen-
tiation of bone marrow cells (e.g., RARA) and of gamma delta T
cells (e.g., JAG2) were also specifically induced in AGMs.
Deficiencies in these functions have already been associated with
disruption of homeostasis in pathogenic HIV/SIV infection
[47,48]. These gene expression patterns are consistent with the
possibility that the AGM may be better poised than the PT to
sustain repopulation of the peripheral hematolymphoid system
after SIV infection [4].
A key to uncovering AIDS pathogenesis could lie in
discerning what is unique to the response of natural hosts to
SIV infection. From the LN d10 ANOVA, 108 genes were
identified as significantly induced only in AGMs (Table S4). The
functions of these genes may serve to protect against disease
progression in the natural host. In addition to those described
above, many genes were associated with leukocyte movement
and adhesion (e.g., DEFA3 and KCNA3), and cell survival and
growth (e.g., DNASE1L3, AXL, and DUSP5). A significant
network linking functions to epidermal growth factor was also
identified by Ingenuity Pathway Analysis (not shown). The
network genes encoded sulfotransferases for glucosamine
signaling (e.g., HS3ST2 and HS3T3A1), actin-binding proteins
(e.g., FSCN2 and CDC42EP1), and proteins required for
cytoskeleton and extracellular matrix structure (e.g., EMILIN1,
TUBA1A, and COL17A1). These patterns indicate that AGMs
may be able to better maintain basic cellular functions
and organ structure, consistent with reports that lymph
node architecture is better preserved during non-pathogenic
infections [49].
Figure 4. Expression of genes associated with IFN-c signaling in lymph node of PT (A) and AGM (B) at day 10. Ingenuity network
analysis showing genes associated with IFNc signaling overlaid with expression data from in-silico pooled samples of PT LNs (A) or AGM LNs (B) at day
10. Genes shown in red and green represent increased or decreased expression, respectively, relative to pre-infection levels.
doi:10.1371/journal.ppat.1000296.g004
Gene Expression Profiling in SIV-Infected NHPs
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Species- and time-dependent gene expression changes
in lymph nodes
We similarly examined the kinetics of gene expression changes
within each species by using ANOVA to compare expression data
by day post-infection, identifying 297 genes whose expression
significantly changed in PT lymph nodes between day 10 and day
45+ (Figure S2A). Many genes induced at day 10 were linked to
apoptosis and oxidative stress, with increased expression of DNA
damage-inducible genes (e.g., SOD2, YWAE, GZMB, GZMH,
BAK1, and PRF1), some of which are specifically associated with
apoptosis of T lymphocytes. This supports the day-10 species
ANOVA, showing early and high expression of genes associated
with stress responses in pathogenic infection and confirms that
these responses are specific to viral peak and abate in LNs
thereafter. About one third of genes identified by the PT time-
dependent ANOVA showed either no change or decreased
expression at peak VL (day 10), followed by strong induction at
day 45+. In general, these genes belonged to the functional
categories of cellular assembly and tissue development. Of these
genes (blue bar in Figure S2A), 41 showed high expression in
AGMs as early as day 10, which persisted to day 45+ (Figure S2B).
The expression of these genes may contribute to a successful
antiviral response or to the maintenance of proper cell homeostasis
in non-pathogenic hosts, but they are induced too late to be
effective during pathogenic infection. Gene ontology analysis
showed that the genes induced earlier in AGMs are necessary for
growth, differentiation, and structure (e.g., RYR2, PCDHGA7,
MYLPF, EEF2K, and CAMK2N2).
The lymph node AGM time ANOVA identified 170 genes
whose expression changed significantly between day 10 and day
45+ post-infection, less than 30 of which were common with the
LN PT time ANOVA (not shown). In contrast to what was
observed in PT, most of these genes were highly induced in AGMs
at day 10 but decreased by day 45+, and many encoded
inflammatory mediators specifically associated with the interferon
response (e.g., IFIT2, IFIT3, STAT1, IFITM2, IFITM3,
CXCL10, and IFIH1). During this same time frame, high
expression of these genes was sustained in PTs. These observations
suggest that attenuation of interferon signaling at the transcrip-
tional level may be an important characteristic of non-pathogenic
SIV infection.
Collectively, analysis of LN revealed that most differential gene
expression patterns in PTs vs. AGMs occurred at peak VL (day 10)
and related to immune responses and cell death. During early
pathogenic infection, species and time ANOVAs revealed high
induction of genes associated with acute stress responses, DNA
damage, and Th1 signaling. In AGMs, however, gene expression
data suggested control of Th1 responses and maintenance of
general cell homeostasis processes, including immune cell
homeostasis. Though expression patterns in LNs of both species
were more similar by day 45+, there was a clear tendency for
sustained inflammatory responses during pathogenic infection,
while IFN signaling was significantly attenuated by day 45+ during
non-pathogenic infection.
Gene expression patterns in peripheral blood
The time- and species-specific gene expression changes in
peripheral blood were very similar to those observed in lymph
nodes. Time ANOVAs in peripheral blood, comparing AGM
expression levels at day 10 to day 45+, further confirmed
evidence for an attenuated inflammatory response during non-
pathogenic infection. Of 109 genes identified by AGM time
ANOVA, one quarter were less induced or down-regulated
by day 45+ (Table S5) and most of these were involved in
IFN-signaling (e.g., MX1, MX2, OAS1, OAS2, CXCl10, IFI35,
IFI27, and ISG20). Expression patterns identified by blood day
45+ species ANOVA (Figure S3) suggested the strong and
sustained induction of genes associated with an inflammatory
response only in PTs (Figure S3, blue bar; Table S6), many of
which can be regulated by IFN (e.g., MX1, MX2, OAS1, and
IFI27). One unique pattern identified by blood day-10 species
ANOVA that was not observed in LNs, was a marked decrease,
only in PTs, in expression levels of most genes at peak viral load
(Table S7). Overall, this broad ‘‘suppressive’’ trend in PTs was
seen in genes associated with the regulation of basic cellular
homeostasis [50], including functions such as apoptosis regula-
tion and the development of cells involved in the immune
response. The decreased expression of these genes may in part be
due to depletion of circulating CD4+ T cells in PTs at 10 days
post-infection, either because of increased destruction, decreased
production, or movement into tissues. Given the low proportion
of CD4+ T cells in blood, however, it is unlikely that such
depletion is responsible for all of these dramatic gene expression
changes
Species similarities of time-dependent gene expression
signatures in colon
In contrast to LN and blood, we found that in the colon there
were more genes that were significantly differentially expressed
between time post-infection (day 10 vs. day 45+) than between
species. The AGM time ANOVA identified 658 genes whose
expression distinguished day 10 from day 45+. Most genes were
unchanged or decreased at day 10 but were highly induced by day
45+, very similar to the PT time ANOVA pattern. In fact, nearly
300 genes from the colon AGM and PT time ANOVAs were in
common (Figure S4). Functions most highly represented by these
genes included tissue development, cell movement, growth and
proliferation, death, and cell-cell signaling. These included genes
encoding scaffolding proteins, muscle filaments, extracellular
matrix components, and cell cycle/apoptosis regulators. Ingenuity
Pathway Analysis was used to identify interactions between nearly
30 genes associated with TGFb signaling and fibronectin (data not
shown). These observations suggest that the expression of genes
related to cell growth, proliferation, and apoptosis remain at
baseline at peak VL and do not increase until late in acute
infection. Collectively, the time ANOVA data suggest that the
majority of SIV-induced transcriptional changes in the colon
occur after peak VL in both species. Since most of the genes
induced at viral set point were emblematic of broad tissue
reconstruction, there appears to be a common response in the
colon of both species that occurs in temporal relationship to the
CD4+ T cell depletion found in each [40,41,51].
Of the nearly 700 genes identified by AGM time ANOVA in
the colon, only a subset of 37 genes was induced at day 10 at high
levels and significantly lower by day 45+. These genes are shown
in Figure 5A, along with the corresponding expression in PTs
(Figure 5B). Most are inflammatory mediators with many involved
in type I interferon signaling, which is consistent with the patterns
identified in the lymph nodes. Though expression levels
consistently decreased in all AGMs, but not in PTs, from day 10
to day 45+, the expression levels of many of these inflammatory
mediators were actually higher in AGMs than PTs at day 10. This
suggests that AGMs not only show attenuation of an inflammatory
response after acute infection, but that a more robust early
inflammatory response in the colon may control viral replication
and subsequent tissue damage. These results are consistent with a
previous study that found an association between a stronger early
IFN response and slower disease progression [52].
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Acute phase response signaling in the colon of
pathogenic SIV model
Perhaps the most surprising finding was that the colon showed the
smallest number of genes statistically distinguishing the two species at
peak VL. This and the time ANOVAs suggest that the host
transcriptional response to SIV infection in colon is similar in both
species, and is consistent with the fact that CD4+ T cells are lost in
each. Similar towhatwas observed inperipheral bloodandLN,more
gene expression changes differed during pathogenic vs. non-
pathogenic infection in the colon at day 10 than at day 45+. Of
165 genes that distinguished PTs from AGMs in the day 10 colon
ANOVA, 74were highly inducedonly in thePTs (Table S8) Pathway
analysis revealed that the top pathways/networks represented by
these up-regulated genes were associated with the acute phase
response. Figure 6 shows the most significant network linking these
genes and centers to the transcriptional regulator, NFkB.Most genes
in the network linked important acute phase response regulators such
as p38MAPK, IL1, SOD2, and CEBPB, which in turn positively
influence the induction of additional inflammatory mediators. The
Toll-like receptor pathway was also prominent, with increased
expression of TLR2 and CD14, possibly reflecting responses to
bacterial products. This supports a report that TLR induction by
Figure 5. Gene expression changes in AGM colon between day 10 and day 45+. (A) Heatmap depicting 37 genes that were highly induced
in AGMs at day 10 and significantly lower by day 45+. (B) Corresponding expression levels for PTs. Genes depicted were 2-fold regulated (P#0.05) in
at least 2 of 8 animals.
doi:10.1371/journal.ppat.1000296.g005
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bacterial products escaping the gut could trigger high expression of
inflammatory mediators [27]. If so, it is evident that these pathways
were not prominent in AGMs (Figure 6B) at this time, so it would
seem unlikely that they were involved in the depletion of mucosal
CD4+ T cells observed in this species.
The end of acute infection (day 45+) was associated with the
expression of 106 genes in the colon that distinguished pathogenic
and non-pathogenic infections (Figure 2C and Table S9). Here,
tissue development and cell movement were identified as the top
functional categories, followed by immune response, cell death,
and proliferation. It has been reported that cell adhesion may play
a role in maintaining the integrity of the mucosal barrier during
pathogenic SIV infection [53] while dysregulation of growth
factors and epithelial repair may compromise barrier integrity
[28,54,55]. Therefore, it was interesting that most of the genes in
the first category associated with membrane development,
extracellular matrix, and cell adhesion (RPL37A, CEACAM1,
CEACAM7, COL4A2, ALOX12, DSC2, WNT3, and MAL)
were either highly induced only in AGMs or showed significantly
decreased expression specifically in PTs. Notably, up-regulation of
structural genes in this species ANOVA was negligible in PTs.
Although both species appeared to initiate programs involving
structural integrity genes by day 45+ (as seen in the time
ANOVAs, Figure S4), subtle changes specific to AGMs may be
part of a mechanism associated with the absence of disease
progression. Evidence for bacterial translocation was again
observed at day 45+ by induction of TLR 4 expression in PTs.
Also, consistent with the observations in LN and peripheral blood,
genes encoding inflammatory mediators were more highly induced
at day 45+ in PT than in AGM colon.
In sum, most gene expression patterns in the colon were
common to both the PT and the AGM, and between the peak of
viremia (day 10) and day 45+ post-infection, animals of each
species revealed significant increases in the expression of genes
responsible for cell growth and development. Species-specific
differences revealed a strong acute phase response in PTs at peak
VL (day 10) while induction of structural genes was most
prominent in AGMs at viral set point (day 45+). Additionally,
though the inflammatory response was high and sustained in PTs,
there was a higher IFN response in AGM colon at day 10, which
was significantly attenuated by day 45+ post-infection.
Discussion
This study used two NHP species to comprehensively analyze
the host response associated with non-pathogenic and pathogenic
SIV infection during the acute phase. Our primary findings are
summarized in Table 1. Most species-specific gene expression
differences occurred in LN at the time of peak VL, and the
majority of time-dependent changes for a given species were in the
colon between day 10 and day 45+. Overall, gene expression
patterns in PTs (pathogenic infection) suggest a strong and
sustained immune activation, including CTL activity and Th1
profiles. In contrast, the intensity and kinetics of the inflammatory
response in AGMs (non-pathogenic infection) suggest strong
interferon signaling at day 10, which was then attenuated by
day 45+. The AGMs also exhibited fewer gene expression changes
related to cell homeostasis (defined here as genes associated with
basic cellular functions, such as metabolism, growth, and
continued hematopoietic regeneration).
Figure 6. Expression of genes associated with acute phase response/NFkB signaling in colon of PT (A) and AGM (B). Ingenuity
network analysis showing connection between genes associated with NFkB signaling overlaid with expression data from in-silico pooled samples of
PT colon (A) or AGM colon (B) at day 10. Genes shown in red and green represent increased or decreased expression, respectively, relative to pre-
infection levels.
doi:10.1371/journal.ppat.1000296.g006
Gene Expression Profiling in SIV-Infected NHPs
PLoS Pathogens | www.plospathogens.org 9 February 2009 | Volume 5 | Issue 2 | e1000296
Although our study is the first to use global gene expression
profiling to compare the host response during pathogenic and non-
pathogenic SIV infection, a number of previous studies have also
used NHP models in which infection outcome differs in an attempt
to elucidate mechanisms associated with disease progression.
Several themes have begun to emerge. For example, Cumont et al
[56] also observed a link between dysregulation of immune
activation and SIV pathogenesis, finding high levels of immune
activation in LN T cell zones of SIV-infected macaques, but low
levels of T cell activation and high levels of B cell activation in
AGMs. This is consistent with our gene expression data. Early
induction of T cell signaling genes during pathogenic infection
supported a trend for Th1 cell differentiation and proliferation,
cytotoxic T cell activity, and extensive IFNc signaling. Increased
IFNc expression, an indicator of the Th1 response, has been
detected in lymphoid tissue of macaques [24,43,57], and
dysregulation of Th1 agonists may contribute to pathogenesis
[58]. In contrast, prominent Th2 cytokine profiles have been
associated with SIV infection during non-pathogenic infection
[59].
Levels of CD8+ T cell activation have been directly correlated
with accelerated AIDS progression [16–18]. In our study, Ki67
levels were statistically higher in PT CD8+ T cells than in AGMs,
and these levels correlated well with gene expression profiles
indicative of a more pronounced CTL response in PTs (e.g., up-
regulation of IFNc, immunoproteasomes, and granzymes). In
contrast, CD8+ T cell Ki67 expression and transcriptional profiles
in the AGM indicated lower levels of T cell activation and less
prominent Th1 patterns [34,60–62]. Although similar observa-
tions have been attributed to a low immune response of AGMs to
core SIVagm protein [63], we found that SIV-specific antigen
responses were similar in both species [39]. This supports studies
finding comparable SIV-specific cellular responses in both
pathogenic and non-pathogenic models of SIV infection [64–
67]. Therefore, the increased expression of genes associated with
CTLs during pathogenic infection may be a result of improperly-
regulated activation of bystander immune cells [34].
Loss of T regulatory cells (Tregs) [68] and cell cycle
dysregulation [69] have been associated with pathogenic SIV-
infection. For example, microarray analyses of macaque LN and
jejunal biopsies [53,57] have shown dysregulation of cell cycle and
increased induction of cytolytic activity as part of a localized host
response. We also observed the acute loss of Tregs during
pathogenic infection and cell cycle dysregulation in the transcrip-
tional analysis of LNs at peak VL. Additionally, high expression
levels of FOXO3, which negatively regulates T cell activation and
autoinflammation [70], were unique to AGM blood (data not
shown). Taken together, this suggests that failure to control T cell
activation/proliferation may contribute to poor outcome [56,62].
Numerous studies have demonstrated that varied levels of
apoptosis, or the induction of apoptosis-related genes, are linked to
species-specific differences in disease susceptibility [34,56,71].
Global gene expression patterns for apoptotic mediators formed a
complex picture in our analysis. Cell death genes made up the
most significant functional group that distinguished PT from
AGMs at day 10 in LN. However, the number of induced genes
associated with death receptor signaling were nearly equal in
AGMs and PTs, while the number of genes associated with
protection from apoptosis were higher in PTs. Higher levels of
annexin staining [39], loss of CD4+ T cell counts, and the
induction of oxidative stress and DNA damage-inducible genes in
PT lymph node and blood suggest an increased apoptotic response
Table 1. Summary of Global Transcriptional Patterns during Pathogenic (PT) and Non-Pathogenic (AGM) SIV Infection.
Lymph Node
AGM PT
D10 q control of Th1 response q Th1 response: CTL signaling, DC maturation, IFNc signaling
q IFNa signaling q oxidative stress, DNA damage
q cell assembly q anti-apoptotic mediators
Maintenance of progenitor cell regeneration q immune activation
D45+ Attenuation of IFN signaling Sustained IFN response
Delayed induction of tissue development
Blood
AGM PT
D10 No change in cell growth Q basic cell homeostasis
D45+ Attenuation of IFN signaling Broad inflammatory response
DNA damage, oxidative stress
Colon
AGM PT
D10 Q cell growth, proliferation and development Q cell growth, proliferation and development
Higher Type I IFN response q Inflammation and damage
q Acute phase response: NFkB signaling, complement, TLR signaling
D45+ q tissue reconstruction q tissue reconstruction
Attenuation of IFN signaling Sustained inflammation
Shown are the most statistically significant patterns suggested by the gene expression data at peak VL (day 10) and post-peak (day 45+) in LN, blood and colon of SIV-
infected animals.
doi:10.1371/journal.ppat.1000296.t001
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in PTs. The anti-apoptotic gene expression pattern in the LN
species ANOVA may point to a negative feedback mechanism in
PTs that attempts to protect the host from excessive cell death.
However, because apoptosis is not generally a transcriptional
event, it is difficult to interpret such gene expression changes and
to directly correlate them with apoptotic events, except as they
relate to increased expression of survival factors.
The increased expression of genes associated with cell damage
and death in PTs may be due in part to high and sustained levels
of inflammation, and several studies have associated such a
response with SIV/HIV pathogenicity [24,28,53,58]. However, it
has been unclear whether there is an immediate anti-inflammatory
environment in AGMs, or whether these animals are even capable
of mounting a Type I IFN response to SIV. Our results
demonstrate that acute SIV infection does indeed activate Type
1 IFN signaling in AGMs. For example, a group of eight IFNa
genes were induced up to 10 fold over pre-infection levels in AGM
LN at peak VL. We have previously shown that IFN can block
SIV replication at early stages of infection in vitro [72], and our
current analysis indicates that early Type I and II IFN responses
may help AGMs to limit SIV pathogenesis.
Thus, AGMs and PTs both appeared to mount an early
antiviral response, although the response of AGMs was stronger,
earlier, and perhaps more effective. By day 45, the IFN response
was significantly attenuated in AGMs, but less so in PTs. It is
possible that IFN signaling was actively suppressed in AGMs
shortly after peak VL, thereby limiting the induction of
inflammatory mediators that would otherwise hasten disease
progression. Alternatively, the lower induction of IFN genes may
be a consequence of lower viral loads in the LN of these animals,
although the same pattern of attenuation was observed in colon,
where viral loads were similar to those observed in PTs.
The strong and early IFN signaling in AGM colon is consistent
with reports suggesting that a strong innate immune response in
mucosal tissue is a mechanism for limiting SIV pathogenesis
[52,53,73]. However, it is also notable that many of the time-
dependent gene expression changes in the colon were common to
both species and were associated with the regulation of structural
genes. This finding indicates that normal cell homeostasis was
disrupted in the context of both pathogenic and non-pathogenic
infection at the primary site of SIV infection [74]. Although the
initial inflammatory environment could lead to damage of the gut
mucosa in both PTs and AGMs [27], the early attenuation of the
response in AGMs may help to reduce such damage. In contrast,
the loss of mucosal integrity in PTs may contribute to pathogenesis
[28,75,76].
In LN, genes encoding growth or hematopoietic factors and
gamma-delta T cell differentiation were significantly more induced
in AGMs than in PTs. Genes encoding proteins implicated in B
cell homing and differentiation, as well as the development and
chemotaxis of mast cells and eosinophils, were also induced in
AGMs. Although this could be due to changes in lymphoid cell
distribution, it is also consistent with the hypothesis that certain
cell subpopulations in the AGM immune system are better
adapted to control SIV infection than their counterparts in the PT.
Superior immune function may also be linked to the unique
induction of cell survival and structural genes observed in AGM
LN, since the destruction of LN architecture is associated with
rapid disease progression in SIV-infected macaques [49]. Al-
though we did not observe LN destruction at the relatively early
time points studied in this experiment, immunological data
showed that PTs had higher levels of immune activation and
apoptosis in lymphoid tissues than did AGMs. AGM-specific
induction of structural genes during early acute infection may also
lead to better preservation of LN architecture at later stages of
infection. Therefore, our gene expression data suggest that AGMs
may be able to maintain overall immune homeostasis through LN
preservation, chemotaxis of certain immune cell subsets, and the
general ability to maintain normal cellular processes despite
continued viral replication.
Global gene expression profiling is increasingly being used to
study lentiviral infection of cell lines, NHPs, and human patients.
Similar to the findings reported here, many of these studies have
also observed differences in the regulation of genes related to
apoptosis and the immune response, including those associated
with IFN signaling, disruption of immune cell homeostasis, and the
preservation of LN architecture [47,57,77–81]. Most intriguing
are similarities in the expression patterns we observed in SIV-
infected AGMs to those identified in lymphoid tissue of HIV
patients on HAART [82]. In both cases, genes associated with
cytotoxic T cells showed a decrease in expression compared to that
observed in SIV-infected PTs or untreated HIV-infected humans.
In contrast, signs of immune activation are attenuated in patients
on HAART, as we observed in AGMs. Genes that contribute to
extracellular matrix structure and that support hematopoietic cell
growth are also induced in patients on HAART. These striking
similarities suggest that mechanisms independent of viral suppres-
sion—possibly the quality of immune activation or resolution—are
different in the context of pathogenic vs. non-pathogenic infection.
These findings also underscore the relevance and reproducibility
of genomic SIV studies for elucidating mechanisms of AIDS
pathogenesis.
In summary, our findings emphasize the importance of tissue
compartmentalization and kinetics in SIV pathogenesis as well as
the unifying pattern of IFN induction and attenuation in the
natural host. Because the greatest number of gene expression
changes distinguishing pathogenic from non-pathogenic infection
occurred in lymph node at peak viral load, we propose that this
may be a promising site and time point for further study. To our
knowledge, this is the first time that such a comprehensive data
set—derived using the macaque genome to directly compare gene
expression profiles during acute stages of pathogenic and non-
pathogenic SIV infection—has been made available to the public.
Materials and Methods
Virus
The original SIVagm.sab92018 primary isolate [6] was kindly
provided by Dr. O. Diop at the Pasteur Institute in Dakar, Senegal
and is CCR5- and CXCR4-duo-tropic [83]. Our viral stock was
obtained by infecting one SIV negative C. sabaeus (Caribbean
origin from the colony at the Center for Primate Neuroethology
and Neuropsychiatric Institute, University of California, Los
Angeles) with 300 50% tissue culture infectious doses (TCID50)
of SIVagm.Sab92018 (Dakar), and by collecting plasma at day
+10 following IV inoculation. The virus stock (pure plasma) was
titrated on SupT1 cells at a titer of 1250 TCID50/ml,
corresponding to 1.066109 RNA copies/ml (as measured by
qRT-PCR; see below) and 7 ng/ml p27 (as measured by p27
ELISA, Zeptometrix, Buffalo, NY) as described in 2 and in
Methods.
SIVagm infection of NHPs and tissue collection
Ethics Statement: All animal and in vitro procedures were
performed using standard protocols and according to guidelines
approved by the University of Washington Environmental Health
and Safety Committee, the Occupational Health Administration,
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the Primate Center Research Review Committee, and the
Institutional Animal Care and Use Committee.
The four adult male AGMs (10 years old, weighing 6.0 kg,
interquartile range 5.8–6.2) and four adult male PTs (11 years old,
weighing 16 kg, IQR 15.3–17.0) included in this study were
housed at the Washington National Primate Research Center
(WaNPRC). At day 0, animals were inoculated intravenously with
600 50% tissue culture infectious doses (TCID50) of SIVagm-
Sab92018 and followed until necropsy at day 45 or day 49
(subsequently noted as day 45+). Blood samples were collected at
days 214, 10, and 45+. At days 214, 10, and 45+, biopsies were
obtained from the colon and lymph nodes (inguinal).
RNA extraction
For microarray and VLs on tissues stored in RNAlater (colon
and lymph node biopsies) or in OCT (lymph node biopsies), tissues
were homogenized using a Polytron PT2100 tissue grinder
(Kinematica, Switzerland) and RNA was extracted using TRIZOL
Reagent according to manufacturer’s instructions (Invitrogen).
Whole blood was collected into PAXgene tubes for RNA
extraction with the PAXgene RNA blood kit (Qiagen, Valencia,
CA). RNA concentrations were quantified on an ND-1000 UV-
Vis spectophotometer (Nanodrop, Wilmington, DE) and con-
trolled for integrity and purity on a capillary electrophoresis system
(Agilent 2100 Bioanalyzer; Agilent Technologies, Santa Clara,
CA) and processed for microarray as described (Kash et al., 2006a;
Kash et al., 2006b; Kobasa et al., 2007)
Viral load measurement
RNA VLs in plasma and tissues were measured by real-time
quantitative PCR (ABI PRISM 7700, Applied Biosystem Foster
City, CA) in a one step RT-PCR reaction (HoTaq One Step-RT
PCR Mix; Molecular Cloning Laboratories, South San Francisco,
CA), using primers and probes as previously described (Diop et al.,
2000).
Expression microarray
Gene expression profiling on whole blood, colon, and LN
biopsies at days 10 and 45+ was compared to the baseline time
point (day 214) for each tissue and each animal. Probe labeling
was performed using Low RNA Input Fluorescent Linear
Amplification kit (Agilent Technologies, Santa Clara, CA). Slide
hybridizations were performed with rhesus macaque (Macaca
mulatta) oligonucleotide microarrays containing 18,000 rhesus
probes (Agilent), representing over 17,000 unique rhesus genes.
The platform used here was based on the 39-UTR sequences of
rhesus transcripts, as identified in the 66-coverage rhesus genome
(MMUL1.1). Based on available sequences, the probes of the
rhesus array have 98% sequence identity to corresponding
sequences in M. nemestrina or M. fascicularis [84]. Extending this
to C. sabaeus, we estimate this to also have better than 97% identity
to M. mulatta.
Each microarray experiment was done with two technical
replicates by reversing dye hybridization for experimental and
reference samples. Slides were scanned with an Agilent DNA
microarray scanner, and image data were processed using Agilent
Feature Extractor Software (Agilent Technologies, Palo Alto, CA),
which also performed error modeling. All data were subsequently
uploaded into Rosetta Resolver 7.0 (Rosetta Biosoftware, Kirk-
land, WA) and Spotfire Decision Suite 8.1 (Spotfire, Somerville,
MA) for data analysis. In accordance with proposed MIAME
(minimum information about a microarray experiment) standards
[85], all data described in this report, including sample
information, intensity measurements, gene lists, error analysis,
microarray content, and slide hybridization conditions, are
publically available at http://viromics.washington.edu.
The Resolver system performs a squeeze operation that creates
ratio profiles by combining replicates while applying error
weighting. The error weighting consists of adjusting for additive
and multiplicative noise. A P value is generated that represents the
probability that a gene is differentially expressed. The Resolver
system then combines ratio profiles to create ratio experiments
using an error-weighted average as described in Roland Stoughton
and Hongyue Dai, Statistical Combining of Cell Expression
Profiles (US Patent #6,351,712, February 26, 2002). For each
microarray experiment, the calculation of mean ratios between
expression levels of each gene in the analyzed sample pair,
standard deviations, and P values was performed using Resolver.
In this study, genes selected for data analysis had a greater than
95% probability of being differentially expressed (P#0.05) and fold
change $2. Ingenuity Pathway Analysis (IPA) software and Entrez
Gene (www.ncbi.nlm.nih.gov/sites) were used for gene ontology
analysis. Analysis of Variance (ANOVA), a factorial-based analysis
method for determining statistical differences between means of
different populations, was used to identify genes that statistically
distinguished either species or time points.
Cell counts, phenotype, and functional analysis by flow
cytometry
Complete blood counts (CBC) were determined at the
WaNPRC Clinical Lab in Seattle as well as by absolute counting
on 50 ml whole blood, using Trucount absolute counting tubes
(BD Biosciences, San Jose, CA). Phenotyping was performed by
cell surface staining. FACS data were analyzed using FlowJo
software with standard gating strategies and then transferred into
analysis and graphic software (Excel, StatView (Abacus Concepts,
Berkeley, CA)). Multifunctional cytokine analysis was performed
after stringent gating of each cytokine positive population and
subsequent Boolean gating (FlowJo).
Supporting Information
Figure S1 Viral loads and CD4 counts in PBMC, colon, LN. A.
Cellular viral loads expressed as number of RNA copies of
SIVagmSab92018 per mg of total cell-associated RNA. Each
animal is represented by a different color and symbol. B.
Frequency of CD4+ T cells among total CD3+ T cells, expressed
as percent CD4+.
Found at: doi:10.1371/journal.ppat.1000296.s001 (0.65 MB TIF)
Figure S2 Time ANOVA in PT lymph node. A. 297 genes from
one-way time ANOVA in PT lymph node distinguished day 10
from day 45+. The blue bar indicates genes that were induced at
day 45+ in PTs. B. Expression levels in AGMs and primary
sequence names for 41 genes from the blue bar selection. Each
column represents gene expression data from an individual
animal. A full view is shown with green and red colors showing
decreased or increased levels of mRNA expression relative to d-14.
Only genes with $2-fold change (P#0.05) in at least 2 of 8
experiments are shown. 2-D hierarchical clustering was performed
using Resolver System software with agglomerative algorithm,
average link heuristic criteria, and Cosine correlation metric.
Found at: doi:10.1371/journal.ppat.1000296.s002 (0.90 MB TIF)
Figure S3 Gene expression profiles distinguishing AGM from
PT in blood. 254 genes were identified by day 45+ species
ANOVA and are shown with cutoffs and clustering as described in
Figure S2. The blue bar indicates 63 genes that were only induced
in PTs at day 45+ and that are listed in Table S6.
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Found at: doi:10.1371/journal.ppat.1000296.s003 (0.81 MB TIF)
Figure S4 Differences in gene expression profiles based on time
post-infection in AGM and PT colon. One-way time ANOVAs in
AGM and PT colon distinguished day 10 from day 45+. 294 genes
were common to time ANOVAs from both species. A. Expression
pattern for 294 common time ANOVA genes in AGMs. Cutoffs
and color schemes are as described in Figure S1. B. The
corresponding expression levels for these genes are also shown in
PTs.
Found at: doi:10.1371/journal.ppat.1000296.s004 (0.42 MB TIF)
Table S1 Cell death genes
Found at: doi:10.1371/journal.ppat.1000296.s005 (0.02 MB XLS)
Table S2 Immune response genes
Found at: doi:10.1371/journal.ppat.1000296.s006 (0.03 MB XLS)
Table S3 Genes uniquely induced in PTs
Found at: doi:10.1371/journal.ppat.1000296.s007 (0.03 MB XLS)
Table S4 Genes uniquely induced in AGMs
Found at: doi:10.1371/journal.ppat.1000296.s008 (0.03 MB XLS)
Table S5 Genes less-induced at d45+ in AGM blood
Found at: doi:10.1371/journal.ppat.1000296.s009 (0.02 MB XLS)
Table S6 Genes up-regulated at d45+ in PT blood
Found at: doi:10.1371/journal.ppat.1000296.s010 (0.02 MB XLS)
Table S7 Genes down-regulated at day 10 in PTs
Found at: doi:10.1371/journal.ppat.1000296.s011 (0.05 MB XLS)
Table S8 Genes up-regulated in PTs from d10 colon species
ANOVA
Found at: doi:10.1371/journal.ppat.1000296.s012 (0.02 MB XLS)
Table S9 Colon d45 species ANOVA
Found at: doi:10.1371/journal.ppat.1000296.s013 (0.03 MB XLS)
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